RXO (NYSE:RXO - Get Free Report) had its target price lifted by equities researchers at Susquehanna from $18.00 to $20.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a "negative" rating on the stock. Susquehanna's target price suggests a potential downside of 26.18% from the stock's current price.
Other equities analysts have also issued reports about the stock. The Goldman Sachs Group reissued a "neutral" rating and set a $18.00 price objective on shares of RXO in a report on Friday, May 8th. TD Cowen boosted their price target on RXO from $14.00 to $21.00 and gave the stock a "hold" rating in a research report on Friday, May 8th. Zacks Research raised RXO from a "strong sell" rating to a "hold" rating in a research report on Monday, April 6th. Weiss Ratings upgraded shares of RXO from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, June 4th. Finally, Stifel Nicolaus raised their price target on shares of RXO from $22.00 to $30.00 and gave the company a "buy" rating in a report on Monday. Four research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $23.14.
Read Our Latest Stock Report on RXO
RXO Stock Performance
Shares of RXO stock opened at $27.09 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. The stock's fifty day moving average price is $25.08 and its 200-day moving average price is $18.67. The firm has a market cap of $4.47 billion, a P/E ratio of -44.42 and a beta of 2.03. RXO has a 12 month low of $10.43 and a 12 month high of $29.86.
RXO (NYSE:RXO - Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported ($0.09) EPS for the quarter, meeting analysts' consensus estimates of ($0.09). RXO had a negative net margin of 1.83% and a negative return on equity of 1.16%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter last year, the firm posted ($0.03) EPS. The company's revenue for the quarter was down .6% on a year-over-year basis. On average, equities research analysts expect that RXO will post 0.08 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. Flagship Harbor Advisors LLC acquired a new stake in shares of RXO during the fourth quarter worth $25,000. Cassaday & Co Wealth Management LLC acquired a new position in shares of RXO in the 1st quarter valued at $29,000. Geneos Wealth Management Inc. purchased a new position in RXO in the 1st quarter worth $30,000. Quarry LP purchased a new position in RXO in the 3rd quarter worth $33,000. Finally, City Holding Co. lifted its position in RXO by 227.6% during the 2nd quarter. City Holding Co. now owns 1,245 shares of the company's stock worth $34,000 after acquiring an additional 865 shares during the period. Institutional investors and hedge funds own 92.73% of the company's stock.
About RXO
(
Get Free Report)
RXO Inc NYSE: RXO is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.